Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
11/2008
11/11/2008US7449493 N-[2-[[1-[[[(2,4-dimethylphenyl)methyl]amino]methyl]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide; monocyte chemoattractant proteins receptor antagonists or partial agonists/antagonists; antiinflammatory agent, autoimmune diseases; rheumatoid arthritis, multiple sclerosis, atherosclerosis
11/11/2008US7449483 e.g. 2-(Ethyl-{4-[2-methyl-3-(4-trifluoromethyl-phenyl)-benzo[b]thiophen-6-yl]-butyl}-amino)-ethanol; 2,3-oxidosqualene-lanosterol cyclase inhibitor; antidiabetic, antitumor, antiproliferative agent; hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones
11/11/2008US7449455 1-[4-(2-azepan-1-yl-ethoxy)-benzyl]-2-(4-hydroxy-phenyl)-3-methyl-1H-indol-5-ol; contraception; melanoma; capable of inhibiting bone loss while showing little or no uterine stimulation, decrease the weight gain, decrease cholesterol levels, prevent bone loss
11/11/2008US7449324 Determining in a sample of an animal the presence of a viral component by reacting the sample with a nucleic acid or an antibody reactive with component of an avian pneumovirus, and crossreactive with a component of MPV (metapneumovirus)
11/06/2008WO2008134297A2 Engineered renal tissue
11/06/2008WO2008133128A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes
11/06/2008WO2008133036A1 Method for screening of therapeutic agent for renal tubular dysfunction
11/06/2008WO2008132846A1 Tricyclic heteroaryl compound
11/06/2008WO2008132025A1 Use of 4-(nitrooxy)-butyl-(s)-2-(6-methoxy-2-naphtyl)-propanoate for treating pain and inflammation
11/06/2008WO2008061011A3 Intra-vascular kidney gene therapy with plasmid encoding bmp-7
11/06/2008US20080275124 Powder of amino acids and method for producing the same
11/06/2008US20080275108 VACUOLAR-TYPE (H+)-ATPase-INHIBITING COMPOUNDS, COMPOSITIONS, AND USES THEREOF
11/06/2008US20080275098 Novel substituted 2-aminoimidazoles, process for their preparation, their use as medicament or diagnostic aid
11/06/2008US20080275095 Packages
11/06/2008US20080275069 3,8-dimethyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]-4(3H)-quinazolinone; 6-chloro-3-methyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]pyrido[3,4-d]-pyrimidin-4(3H)-one; 2-[4-(1-cyclopentyl-4-piperidinyloxy)phenyl]-3-methylpyrido[2,3-d]-pyrimidin-4(3H)-one; treats metabolic, nervous system, vascular disorders
11/06/2008US20080275047 Tetrahydro-naphthalene derivatives
11/06/2008US20080275015 Aqueous solution directly into bladder; mixture of an antihistamine, steroid antiinflammatory drug, anticonvulsant, and amino acid
11/06/2008US20080275008 Modulate sphingosine-1-phosphate (S1P) receptors with fewer side effects; for example, 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentylphosphonic acid monoester; prophylactic or therapeutic agents against rejection of organ transplants, skin grafts, rheumatoid arthritis, lupus
11/06/2008US20080274212 Extract of Tinospora cordifolia; immunoadjuvant; chronic recurrent urinary tract infections; nephrotic syndrome; Glomerulonephritis
11/06/2008US20080274162 Composition of Lactobacillus bacteria and a carrier; rectal delivery providesoptimum method of transmission of the treatment
11/06/2008CA2683488A1 Use of 4-(nitrooxy)-butyl-(s)-2-(6-methoxy-2-naphtyl)-propanoate for treating pain and inflammation
11/06/2008CA2682400A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes
11/05/2008EP1988395A1 Methods for evaluating tissue morphogenesis and morphogenic activity
11/05/2008EP1988163A1 Hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same
11/05/2008EP1988097A1 Compositions and methods for the therapy and diagnosis of prostate cancer
11/05/2008EP1988091A1 Tricyclic compounds
11/05/2008EP1986627A2 Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases
11/05/2008EP1385514B1 Spiroindene and spiroindane compounds
11/05/2008EP1223941B1 Therapeutic treatments for blood cell deficiencies using sreroids
11/05/2008EP1162990B1 Treatment with small peptides to effect antifibrotic activity
11/05/2008CN101300235A Diaminopyrimidines as P2X3 and P2X2/3 modulators
11/05/2008CN101300008A Rapamycin derivative or an IMPDH inhibitor for treating polycystic kidney disease
11/05/2008CN101298440A Pharmaceutical salts of reboxetine
11/05/2008CN101297963A Pharmaceutical composition of proinsulin C peptide
11/05/2008CN101297944A Chinese medicinal composition for preventing and treating hepatonephromegaly of bird
11/05/2008CN101297880A Active extract containing phlorizin and uses thereof
11/05/2008CN101297693A Method for processing mushroom powder
11/05/2008CN100430402C Method of refining plamatine from herba fibranreae recisae total ulkuloid and its application
11/05/2008CN100430396C 2-phenyl-substituted imidazo-triazone used as phosphodiesterase inhibitor
11/05/2008CN100430069C Reversible heat gelling aquatic pharmaceutical composition of a Chinese medicine and compound prescription thereof
11/05/2008CN100430048C Alpha-2-delta ligand to treat lower urinary tract symptoms
11/05/2008CN100430045C Radix bupleuri dripping pill and its preparing method
11/04/2008US7446222 2-benzyloxy-5-chloro-[1,1';2',1'']terphenyl-3''-carboxylic acid; neuropathic pain; chronic articular pain (e.g. rheumatoid arthritis, osteoarthritis, rheumatoid spondylitis, gouty arthritis and juvenile arthritis) including the property of disease modification and joint structure preservation
11/04/2008US7446183 Fusion protein comprising growth hormone and growth hormone receptor
11/04/2008US7446175 Antibodies to human IL-1β
11/04/2008US7446123 Azabicyclo derivatives as muscarinic receptor antagonists
11/04/2008US7446105 4-(1,2-diethyl-4-methylimidazol-5-yl)-2-{4-[N-(2-methoxyethyl)sulphamoyl]anilino}pyrimidine; selectivity for cyclin-dependent serine/threonine kinases (CDK2, CDK4 and CDK6); antiproliferative agent; minimize pharma toxicity on S-phase cell cycle, G2 or mitosis; oncogene signalling pathways
11/04/2008US7446091 Methods and preparations for curing clinically ill patients
11/04/2008US7445784 Apoptosis of rectum and prostate cancer
10/2008
10/30/2008WO2008129994A1 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes
10/30/2008WO2008129802A1 Agent for lowering serum uric acid level and food or drink with indication of lowering serum uric acid level
10/30/2008WO2008128832A1 Nitroderivatives of non-peptidic renin inhibitors for the treatment of cardiovascular, renal and chronic liver disease, inflammations and metabolic syndrome
10/30/2008US20080269487 6-{[1-(carbamoylmethyl)piperidin-4-yl]oxy}-4-(3-chloro-2-fluoroanilino)-7-methoxyquinazoline; prevent, treat tumours which are sensitive to inhibition of erbB receptor tyrosine kinases
10/30/2008US20080269349 administering an isolated astaxanthin and a mono- or di-ester thereof; controlling cytokine or TGF- alpha -related gene expression; reducing muscle atrophy, treating diabetes
10/30/2008US20080269260 Using a purine compound; antiallergens; antiinflammatory agents; cognition activators; drug abuse; schizophenia; Alzheimer's disease; Parkinson's disease
10/30/2008US20080269238 Thiazolopyrimidine Derivative
10/30/2008US20080269226 Methods for Preserving Renal Function Using Xanthine Oxidoreductase Inhibitors
10/30/2008US20080269156 Antisense strand, sense strand are non-phosphorylated at the 5' and 3' termini; pulmonary, eye, microvascular, hearing disorders; target for hypoxia-inducible factor-1 that may regulate hypoxia-induced pathogenesis independent of growth factors such as VEGF
10/30/2008US20080269155 Remedy or preventive for kidney disease and method of diagnosing kidney disease
10/30/2008US20080269150 Intra-vascular kidney gene therapy with plasmid encoding BMP-7
10/30/2008US20080269128 Albumin Fusion Proteins
10/30/2008US20080269127 Albumin Fusion Proteins
10/30/2008US20080269126 Albumin Fusion Proteins
10/30/2008US20080269125 Albumin Fusion Proteins
10/30/2008US20080269123 Using modulator of tumor necrosis factor (TNF) pathway such as infliximab, simvastatin; drug screening
10/30/2008US20080267962 Albumin Fusion Proteins
10/30/2008US20080267877 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis
10/30/2008CA2680769A1 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes
10/29/2008EP1986011A2 Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
10/29/2008EP1985297A1 Carboxylic acid compound and use thereof
10/29/2008EP1984329A2 Vitamin d analog - rak, methods and uses thereof
10/29/2008EP1984010A2 Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
10/29/2008EP1984001A1 Fixed-dose association of phytate and zinc
10/29/2008EP1983990A1 A3 adenosine receptor allosteric modulators
10/29/2008EP1406650B1 Use of poly-glu, tyr for neuroprotection therapy of the cns or pns
10/29/2008CN101296925A Novel benzopyran derivatives as potassium channel openers
10/29/2008CN101296907A Diaminopyrimidines as P2X3 and P2X2/3 modulators
10/29/2008CN101294128A Truffle soaked wine
10/29/2008CN101293054A Chinese Medicinal composition for treating kidney Qi deficiency
10/29/2008CN101293052A Traditional Chinese medicine for treating diabetes complications and preparation method thereof
10/29/2008CN101293004A Medicament for treating chyluria
10/29/2008CN101292993A Method for preparing urea, creatinine adsorption agent-oxycellulose base ester picronitric acid
10/29/2008CN101292719A Kidney-tonifying hair-blackening hairdressing bean and preparation method
10/29/2008CN101292685A Health care edible oil
10/29/2008CN100429232C Vaughan Tristan J.
10/29/2008CN100429210C Substituted 6h-dibenzo[c,h]chromenes as estrogenic agents
10/28/2008US7442790 Caspase inhibitors and uses thereof
10/28/2008US7442763 Kidney diseases
10/28/2008US7442717 Compounds for treatment of sleep apnea, respiratory system disorders or kidney failure
10/28/2008US7442708 Inhibitors of basic fibroblast growth factors (FGFs); treating cancer, rheumatoid arthritis, inflammatory bowel disease, cardiovascular disorders, diabetic retinopathy, achondroplasia, hypochondoplasia, or thanathophoric dysplasia
10/28/2008US7442702 Prostaglandin agonists
10/28/2008US7442697 4-imidazolyl substituted pyrimidine derivatives with CDK inhibitory activity
10/28/2008US7442546 Method of modulating inflammatory response
10/28/2008US7442387 Pharmaceutical composition for controlled release of active substances and manufacturing method thereof
10/28/2008CA2556514C Composition for oral administration of tamsulosin hydrochloride and controlled release granule formulation comprising same
10/28/2008CA2472107C Dibenzodiazepine derivates, their preparation and use
10/28/2008CA2417652C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
10/28/2008CA2403152C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
10/23/2008WO2008128028A2 Solifenacin compositions
10/23/2008WO2008126920A1 Remedy for diabetes
1 ... 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 ... 562